Data di Pubblicazione:
2019
Abstract:
Therapeutic efficacy in inflammatory diseases is hampered by disease complexity. A monoclonal antibody that neutralizes IL-1R3, the common co-receptor of most inflammatory IL-1 cytokines, opens up new perspectives in effective disease management.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
Antibody therapy
Elenco autori:
Boraschi, Diana
Link alla scheda completa:
Pubblicato in: